Autres langues DSS, Inc.

Actions

DSS

US26253C2017

Emballages papier

Marché Fermé - NYSE 22:10:00 21/08/2026			Varia. 5j.	Varia. 1 janv.
0,5400 ^USD	-1,82%		-4,44%	-41,80%

14/08	DSS, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
15/05	DSS, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

14/08	DSS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
09/06	DSS, Inc. Withdraws Registration Statement
15/05	DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
08/05	Dss reports going concern audit opinion in 2025 10-K filing
08/05	DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
15/04	Dss Inc actively evaluating acquisition opportunities within folding carton space
15/04	DSS, Inc. Letter to Shareholders
15/04	Alset International Limited Appoints WONG HIU PAN as Independent Non-Executive Director, Effective April 30, 2026
31/03	DSS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
31/03	DSS, Inc. Auditor Raises 'Going Concern' Doubt
27/03	Alset International to Invest $2.5 Million in DSS
26/03	DSS, Inc. announced that it expects to receive $2.45 million in funding from Alset International Limited
22/03	9,092,518 Common Stock of DSS, Inc. are subject to a Lock-Up Agreement Ending on 22-MAR-2026.
05/02	DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering
04/02	Dss, Inc. announces pricing of $1.0 million underwritten public offering
04/02	DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering
04/02	DSS, Inc. Announces Launch of Proposed Public Offering
14/11	DSS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
26/09/25	Nigeria court orders separatist Kanu to face trial, rejects bid to dismiss charges
14/08/25	DSS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
28/07/25	Impact BioMedical Signs Debt Conversion Agreement with DSS
28/07/25	Impact Biomedical says on July 21 entered debt conversion agreement with DSS
24/06/25	DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
23/06/25	Dr Ashleys Limited entered into a Merger and Share Exchange Agreement to acquire Impact BioMedical Inc. from DSS BioHealth Security, Inc, DSS, Inc., DSS Pure Air, Inc. and others in a reverse merger transaction.
22/05/25	DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth